FDA backs Pfizer COVID-19 boosters for seniors, high-risk
(AP)- The U.S. has moved a step closer to offering booster doses of Pfizer’s COVID-19 vaccine to seniors and others at high risk from the virus.
The Food and Drug Administration on
Continue Reading »